Lupine Publishers-Gastroenterology Journal




Mesenteric Venous Ischemia Secondary to Thrombophilia: Case Report by Amer N in Current Trends in Gastroenterology and Hepatology in Lupine Publishers

Mesenteric ischaemia is an uncommon condition with high mortality and morbidity, the causes can be embolic, thrombotic arterial or venous. Mesenteric venous thrombosis is an uncommon cause of bowel infarction, and it accounts for only 2-10% of the cases of Mesenteric Bowel ischaemia. We are reporting an interesting and uncommon case a fifty-year-old Filipina lady, not known to have any previous medical problems, presented to us with severe abdominal pain with minimal signs. Her CT scan confirmed Mesenteric Venous ischaemia and Bowel infarction. The lady was found to suffer from Protein C and S deficiency.





For more Lupine Publishers Open Access Journals Please visit our website:http://www.lupinepublishers.com/
For more  Gastroenterology open access journal articles Please Click Here:https://lupinepublishers.com/gastroenterology-hepatology-journal/index.php

Comments

Post a Comment

Popular posts from this blog

The Use of Sodium-Glucose Cotransporter 2 Inhibitors in Non-Alcoholic Fatty Liver Disease

  Opinion Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of progressive liver abnormalities from simple hepatic steatosis to non-alcoholic steatohepatitis (NASH) to advanced fibrosis, cirrhosis, and/or hepatocellular carcinoma [1]. Parallel to the rising burden of obesity and metabolic syndrome, NAFLD has emerged as the leading cause of chronic liver disease at an estimated global prevalence of 24% [2]. Besides its known clinical burden for liver-related morbidity and mortality, NAFLD is potentially linked with other extra-hepatic chronic diseases and may be considered a multisystem condition. Particularly, NAFLD increases the risk of type 2 diabetes, cardiovascular diseases, chronic kidney disease, and all-cause mortality [1]. Potential pathophysiologic mechanisms underlying the detrimental effects of NAFLD include hyperglycemia, systemic inflammation, and increased oxidative stress [3]. Sodiumglucose cotransporter 2 (SGLT2) inhibitors are a new class of anti
Read more

Acute Upper Gastrointestinal Bleeding (UGIB) In A Resource Limited Setting Highly Endemic for Viral Hepatitis B: Which Etiologies for Which Real Clinical Practices?

  Abstract Aim : To determine the aetiologies of acute upper gastrointestinal bleeding (UGIB) in a setting highly endemic for hepatitis B and to describe actual clinical practices in a resource-limited setting. Patients and methods: This study was conducted in two parts. The first part was retrospective from January 1st 2010, to December 31st 2019 on the epidemiological profile of UGIB and the second was a prospective study from December 1st 2017 to May 31st 2018 to evaluate, in a blinded experiment, the actual clinical practices in front of an acute UGIB at the emergency units in Yaounde (Cameroon), and included: recognizing UGIB, assessing for severity, taking emergency measures and prescribing emergency Eosogastroduodenal endoscopy (EGDE). Results : During the retrospective period, 506 patients (prevalence of acute UGIB in the services 5.6%) were included of which 71.3% were men (sex ratio 2.5). The mean age was 49.9 +/- 8 years. Haematemesis was inaugural in 350 pa
Read more

Post-COVID-19 GI Manifestations: Are We in for the “Long Haul”?

Abstract Post-COVID-19 gastrointestinal (GI) disease management remains a clinical challenge as the medical literature continues to evolve and expand. Reports of excess GI disease burden across the population, as well as prescribed use of pharmaceuticals for symptom relief, have proven “long-haul” GI disease is prevalent across the population. This article will help to summarize the current medical literature as it pertains to post-COVID-19 GI clinical presentations, dysbiosis, functional disorders and evidence of lasting liver and biliary injury implications. Increased awareness of the GI implications for this paradigm hopefully will lead to a better understanding of the pathophysiology, as well as natural history and potential therapeutic approaches. Read more about this article: https://lupinepublishers.com/gastroenterology-hepatology-journal/fulltext/post-covid-19-gi-manifestations-are-we-in-for-the-long-haul.ID.000158.php  Read more about Lupine Publishers Google
Read more